It seems that the active metabolite of LEF, A77 1726, interferes with dendritic cell function and impairs some events that involve the JAK/STAT pathway and control proinflammatory TNF and IL-17 cytokine production which are all involved in the pathogenesis of GCA and PMR [13–15]. The gene discussed is IL17A; the disease is temporal arteritis.